Omega-3 Fatty Acids and Vulnerability to Addiction: Reviewing Preclinical and Clinical Evidence

Valerie    L.    Darcey; Katherine    M.    Serafine
doi:10.2174/1381612826666200429094158
Abstract

Omega-3 (N3) fatty acids are dietary nutrients that are essential for human health. Arguably, one of their most critical contributions to health is their involvement in the structure and function of the nervous system. N3 fatty acids accumulate in neuronal membranes through young adulthood, becoming particularly enriched in a brain region known to be the locus of cognitive control of behavior-the prefrontal cortex (PFC). The PFC undergoes a surge in development during adolescence, coinciding with a life stage when dietary quality and intake of N3 fatty acids tend to be suboptimal. Such low intake may impact neurodevelopment and normative development of cognitive functions suggested to be protective for the risk of subsequent substance and alcohol use disorders (UD). While multiple genetic and environmental factors contribute to risk for and resilience to substance and alcohol use disorders, mounting evidence suggests that dietary patterns early in life may also modulate cognitive and behavioral factors thought to elevate UD risk (e.g., impulsivity and reward sensitivity). This review aims to summarize the literature on dietary N3 fatty acids during childhood and adolescence and risk of executive/ cognitive or behavioral dysfunction, which may contribute to the risk of subsequent UD. We begin with a review of the effects of N3 fatty acids in the brain at the molecular to cellular levels–providing the biochemical mechanisms ostensibly supporting observed beneficial effects. We continue with a review of cognitive, behavioral and neurodevelopmental features thought to predict early substance and alcohol use in humans. This is followed by a review of the preclinical literature, largely demonstrating that dietary manipulation of N3 fatty acids contributes to behavioral changes that impact drug sensitivity. Finally, a review of the available evidence in human literature, suggesting an association between dietary N3 fatty and neurodevelopmental profiles associated with risk of adverse outcomes including UD. We conclude with a brief summary and call to action for additional research to extend the current understanding of the impact of dietary N3 fatty acids and the risk of drug and alcohol UD.
Keywords: Omega-3, fatty acids, addiction, substance use disorder, alcohol use disorder, adolescence.
« Previous Next »
[1] 
McCabe SE, West BT, Jutkiewicz EM, Boyd CJ. Multiple DSM-5 substance use disorders: A national study of US adults. Hum Psychopharmacol  2017; 32(5): e2625
[http://dx.doi.org/10.1002/hup.2625] [PMID: 28750478] 
[2] 
Gryczynski J, Schwartz RP, O’Grady KE, Restivo L, Mitchell SG, Jaffe JH. Understanding patterns of high-cost health care use across different substance user groups. Health Aff (Millwood)  2016; 35(1): 12-9.
[http://dx.doi.org/10.1377/hlthaff.2015.0618] [PMID: 26733696] 
[3] 
Kreek MJ, LaForge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov  2002; 1(9): 710-26.
[http://dx.doi.org/10.1038/nrd897] 
[4] 
Schramm-Sapyta NL, Walker QD, Caster JM, Levin ED, Kuhn CM. Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models. Psychopharmacology  2009; 206(1): 1-21.
[http://dx.doi.org/10.1007/s00213-009-1585-5] 
[5] 
Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci  2005; 8(11): 1450-7.
[http://dx.doi.org/10.1038/nn1583] 
[6] 
Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring
  the Future national survey results on drug use, 1975-2018:
  Overview, key findings on adolescent drug use. Ann Arbor: institute
  for Social Research, University of Michigan 
[7] 
Behrendt S, Wittchen HU, Höfler M, Lieb R, Beesdo K. Transitions from first substance use to substance use disorders in adolescence: is early onset associated with a rapid escalation? Drug Alcohol Depend  2009; 99(1-3): 68-78.
[http://dx.doi.org/10.1016/j.drugalcdep.2008.06.014] [PMID: 18768267] 
[8] 
Wittchen H U, et al. What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention. Int J Methods Psychiatr Res  2008; 17(Suppl. 1): S16-29.
[http://dx.doi.org/10.1002/mpr.254] 
[9] 
Irwin M, Schuckit M, Smith TL. Clinical importance of age at onset in type 1 and type 2 primary alcoholics. Arch Gen Psychiatry  1990; 47(4): 320-4.
[http://dx.doi.org/10.1001/archpsyc.1990.01810160020003] [PMID: 2322083] 
[10] 
Odgers CL, Caspi A, Nagin DS, et al. Is it important to prevent early exposure to drugs and alcohol among adolescents? Psychol Sci  2008; 19(10): 1037-44.
[http://dx.doi.org/10.1111/j.1467-9280.2008.02196.x] [PMID: 19000215] 
[11] 
Swendsen J, Burstein M, Case B, et al. Use and abuse of alcohol and illicit drugs in US adolescents: results of the National Comorbidity Survey-Adolescent Supplement. Arch Gen Psychiatry  2012; 69(4): 390-8.
[http://dx.doi.org/10.1001/archgenpsychiatry.2011.1503] [PMID: 22474107] 
[12] 
Dawson DA. The link between family history and early onset alcoholism: earlier initiation of drinking or more rapid development of dependence? J Stud Alcohol  2000; 61(5): 637-46.
[http://dx.doi.org/10.15288/jsa.2000.61.637] [PMID: 11022800] 
[13] 
Sarris J, Logan AC, Akbaraly TN, et al. International Society for Nutritional Psychiatry Research. Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry  2015; 2(3): 271-4.
[http://dx.doi.org/10.1016/S2215-0366(14)00051-0] [PMID: 26359904] 
[14] 
Puhl MD, Cason AM, Wojnicki FHE, Corwin RL, Grigson PS. A history of bingeing on fat enhances cocaine seeking and taking. Behav Neurosci  2011; 125(6): 930-42.
[http://dx.doi.org/10.1037/a0025759] [PMID: 21988520] 
[15] 
Baladi MG, Daws LC, France CP. You are what you eat: influence of type and amount of food consumed on central dopamine systems and the behavioral effects of direct- and indirect-acting dopamine receptor agonists. Neuropharmacology  2012; 63(1): 76-86.
[http://dx.doi.org/10.1016/j.neuropharm.2012.02.005] 
[16] 
McGuire BA, Baladi MG, France CP. Eating high-fat chow enhances sensitization to the effects of methamphetamine on locomotion in rats. Eur J Pharmacol  2011; 658(2-3): 156-9.
[http://dx.doi.org/10.1016/j.ejphar.2011.02.027] [PMID: 21371470] 
[17] 
Collins GT, Chen Y, Tschumi C, et al. Effects of consuming a diet high in fat and/or sugar on the locomotor effects of acute and repeated cocaine in male and female C57BL/6J mice. Exp Clin Psychopharmacol  2015; 23(4): 228-37.
[http://dx.doi.org/10.1037/pha0000019] [PMID: 26237320] 
[18] 
Blanco-Gandía MC, Cantacorps L, Aracil-Fernández A, et al. Effects of bingeing on fat during adolescence on the reinforcing effects of cocaine in adult male mice. Neuropharmacology  2017; 113(Pt A): 31-44.
[http://dx.doi.org/10.1016/j.neuropharm.2016.09.020] [PMID: 27666001] 
[19] 
2015 - 2020 Dietary Guidelines for Americans. 8th Edition. December. 2015.Available at:  https://health.gov/our-work/food-and-nutrition/2015-2020-dietary-guidelines/
[20] 
Bhanpuri NH, Hallberg SJ, Williams PT, et al. Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study. Cardiovasc Diabetol  2018; 17(1): 56.
[http://dx.doi.org/10.1186/s12933-018-0698-8] [PMID: 29712560] 
[21] 
Hall KD, Chung ST. Low-carbohydrate diets for the treatment of obesity and type 2 diabetes Current Opinion in Clinical Nutrition and Metabolic Care.  Lippincott Williams and Wilkins 2018; pp. 01308-12.
[http://dx.doi.org/10.1097/MCO.0000000000000470] 
[22] 
Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr  1999; 70(3)(Suppl.): 560S-9S.
[http://dx.doi.org/10.1093/ajcn/70.3.560s] [PMID: 10479232] 
[23] 
Becic T, Studenik C. Effects of omega-3 supplementation on adipocytokines in prediabetes and type 2 diabetes mellitus: Systematic review and meta-analysis of randomized controlled trials. Diabetes Metabol J  2018; 42(2): 101-16.
[http://dx.doi.org/10.4093/dmj.2018.42.2.101] 
[24] 
Sartorelli DS, Damião R, Chaim R, Hirai A, Gimeno SGA, Ferreira SRG. Japanese-Brazilian Diabetes Study Group. Dietary ω-3 fatty acid and ω-3: ω-6 fatty acid ratio predict improvement in glucose disturbances in Japanese Brazilians. Nutrition  2010; 26(2): 184-91.
[http://dx.doi.org/10.1016/j.nut.2009.03.013] [PMID: 19647413] 
[25] 
Krishnan S, Steffen LM, Paton CM, Cooper JA. Impact of dietary fat composition on prediabetes: a 12-year follow-up study. Public Health Nutr  2017; 20(9): 1617-26.
[http://dx.doi.org/10.1017/S1368980016003669] [PMID: 28137328] 
[26] 
Flachs P, Rossmeisl M, Kopecky J. The effect of n-3 fatty acids on glucose homeostasis and insulin sensitivity. Physiol Res  2014; 63(SUPPL. 1): S93-S118.
[27] 
Lands B. Dietary omega-3 and omega-6 fatty acids compete in producing tissue compositions and tissue responses. Mil Med  2014; 179(11)(Suppl.): 76-81.
[http://dx.doi.org/10.7205/MILMED-D-14-00149] [PMID: 25373089] 
[28] 
Das UN. Essential Fatty acids - a review. Curr Pharm Biotechnol  2006; 7(6): 467-82.
[http://dx.doi.org/10.2174/138920106779116856] [PMID: 17168664] 
[29] 
Sheppard KW, Cheatham CL. Omega-6/omega-3 fatty acid intake of children and older adults in the U.S.: dietary intake in comparison to current dietary recommendations and the Healthy Eating Index. Lipids Health Dis  2018; 17(1): 43.
[http://dx.doi.org/10.1186/s12944-018-0693-9] [PMID: 29523147] 
[30] 
Spector AA, Kim HY. Discovery of essential fatty acids. J Lipid Res  American Society for Biochemistry and Molecular Biology. 2015; 56(1)
[http://dx.doi.org/10.1194/jlr.R055095] 
[31] 
Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci  2014; 15(12): 771-85.
[http://dx.doi.org/10.1038/nrn3820] [PMID: 25387473] 
[32] 
Bradbury J. Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain. Nutrients  2011; 3(5): 529-54.
[http://dx.doi.org/10.3390/nu3050529] [PMID: 22254110] 
[33] 
Stillwell W, Wassall SR. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids  2003; 126(1): 1-27.
[http://dx.doi.org/10.1016/S0009-3084(03)00101-4] [PMID: 14580707] 
[34] 
McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids  2006; 75(4-5): 329-49.
[http://dx.doi.org/10.1016/j.plefa.2006.07.010] [PMID: 16949263] 
[35] 
Carver JD, Benford VJ, Han B, Cantor AB. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res Bull  2001; 56(2): 79-85.
[http://dx.doi.org/10.1016/S0361-9230(01)00551-2] [PMID: 11704343] 
[36] 
Abbott SK, Else PL, Atkins TA, Hulbert AJ. Fatty acid composition of membrane bilayers: importance of diet polyunsaturated fat balance. Biochim Biophys Acta  2012; 1818(5): 1309-17.
[http://dx.doi.org/10.1016/j.bbamem.2012.01.011] [PMID: 22285120] 
[37] 
Yakah W, Singh P, Perides G, Brown J, Freedman SD, Martin CR. Developmental accretion of docosahexaenoic acid is independent of fatty acid transporter expression in brain and lung tissues of C57BL/6 and Fat1 mice. J Nutr  2019; 149(10): 1724-31.
[http://dx.doi.org/10.1093/jn/nxz074] [PMID: 31179494] 
[38] 
Hulbert AJ, Turner N, Storlien LH, Else PL. Dietary fats and membrane function: implications for metabolism and disease. Biol Rev Camb Philos Soc  2005; 80(1): 155-69.
[http://dx.doi.org/10.1017/S1464793104006578] [PMID: 15727042] 
[39] 
Harris WS. Assessing fatty acid biostatus: Red blood cells or plasma? Lipid Technol  2013; 25(8): 179-81.
[http://dx.doi.org/10.1002/lite.201300290] 
[40] 
Connor WE, Neuringer M, Lin DS. Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J Lipid Res  1990; 31(2): 237-47.
[PMID: 2139096] 
[41] 
Moriguchi T, Salem N Jr. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem  2003; 87(2): 297-309.
[http://dx.doi.org/10.1046/j.1471-4159.2003.01966.x] [PMID: 14511107] 
[42] 
Galli C, White HB Jr, Paoletti R. Brain lipid modifications induced by essential fatty acid deficiency in growing male and female rats. J Neurochem  1970; 17(3): 347-55.
[http://dx.doi.org/10.1111/j.1471-4159.1970.tb02221.x] [PMID: 5494064] 
[43] 
Liu M-J, Li HT, Yu LX, et al. A correlation study of dha dietary intake and plasma, erythrocyte and breast milk dha concentrations in lactating women from coastland, Lakeland, and inland areas of China. Nutrients  2016; 8(5): 312.
[http://dx.doi.org/10.3390/nu8050312] [PMID: 27213448] 
[44] 
Diau G-Y, Hsieh AT, Sarkadi-Nagy EA, Wijendran V, Nathanielsz PW, Brenna JT. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med  2005; 3(11): 11.
[http://dx.doi.org/10.1186/1741-7015-3-11] [PMID: 15975147] 
[45] 
Schipper L, van Dijk G, Broersen LM, et al. A postnatal diet containing phospholipids, processed to yield large, phospholipid-coated lipid droplets, affects specific cognitive behaviors in healthy male mice. J Nutr  2016; 146(6): 1155-61.
[http://dx.doi.org/10.3945/jn.115.224998] [PMID: 27146919] 
[46] 
Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr  1994; 60(2): 189-94.
[http://dx.doi.org/10.1093/ajcn/60.2.189] [PMID: 7913291] 
[47] 
Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res  2008; 47(2): 147-55.
[http://dx.doi.org/10.1016/j.plipres.2007.12.004] [PMID: 18198131] 
[48] 
Brenna JT, Salem N Jr, Sinclair AJ, Cunnane SC. International Society for the Study of Fatty Acids and Lipids, ISSFAL. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids  2009; 80(2-3): 85-91.
[http://dx.doi.org/10.1016/j.plefa.2009.01.004] [PMID: 19269799] 
[49] 
Domenichiello AF, Kitson AP, Bazinet RP. Is docosahexaenoic acid synthesis from α-linolenic acid sufficient to supply the adult brain? Prog Lipid Res  2015; 59: 54-66.
[http://dx.doi.org/10.1016/j.plipres.2015.04.002] [PMID: 25920364] 
[50] 
Gerster H. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int J Vitam Nutr Res  1998; 68(3): 159-73.
[PMID: 9637947] 
[51] 
Plourde M, Cunnane SC. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab  2007; 32(4): 619-34.
[http://dx.doi.org/10.1139/H07-034] [PMID: 17622276] 
[52] 
Lands WE, Libelt B, Morris A, et al. Maintenance of lower proportions of (n - 6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n - 3) fatty acids. Biochim Biophys Acta  1992; 1180(2): 147-62.
[http://dx.doi.org/10.1016/0925-4439(92)90063-S] [PMID: 1463766] 
[53] 
Lin YH, Shah S, Salem N Jr. Altered essential fatty acid metabolism and composition in rat liver, plasma, heart and brain after microalgal DHA addition to the diet. J Nutr Biochem  2011; 22(8): 758-65.
[http://dx.doi.org/10.1016/j.jnutbio.2010.06.008] [PMID: 21111595] 
[54] 
Wu A, Ying Z, Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma  2004; 21(10): 1457-67.
[http://dx.doi.org/10.1089/neu.2004.21.1457] [PMID: 15672635] 
[55] 
Barceló-Coblijn G, Murphy EJ, Othman R, Moghadasian MH, Kashour T, Friel JK. Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am J Clin Nutr  2008; 88(3): 801-9.
[http://dx.doi.org/10.1093/ajcn/88.3.801] [PMID: 18779299] 
[56] 
Cottin SC, Sanders TA, Hall WL. The differential effects of EPA and DHA on cardiovascular risk factors. Proc Nutr Soc  2011; 70(2): 215-31.
[http://dx.doi.org/10.1017/S0029665111000061] [PMID: 21349231] 
[57] 
Mitchell DC, Gawrisch K, Litman BJ, Salem N Jr. Why is docosahexaenoic acid essential for nervous system function? Biochem Soc Trans  1998; 26(3): 365-70.
[http://dx.doi.org/10.1042/bst0260365] [PMID: 9765880] 
[58] 
Alessandri J, Guesnet P, Astorg P, et al. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev  2004; 44(6): 509-38.
[59] 
Suzuki H, Park SJ, Tamura M, Ando S. Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet. Mech Ageing Dev  1998; 101(1-2): 119-28.
[http://dx.doi.org/10.1016/S0047-6374(97)00169-3] [PMID: 9593318] 
[60] 
Delion S, Chalon S, Guilloteau D, Besnard JC, Durand G. alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem  1996; 66(4): 1582-91.
[http://dx.doi.org/10.1046/j.1471-4159.1996.66041582.x] [PMID: 8627314] 
[61] 
Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience  2006; 139(3): 991-7.
[http://dx.doi.org/10.1016/j.neuroscience.2006.01.021] [PMID: 16527422] 
[62] 
Innis SM. Dietary omega 3 fatty acids and the developing brain. Brain Res  2008; 1237: 35-43.
[http://dx.doi.org/10.1016/j.brainres.2008.08.078] [PMID: 18789910] 
[63] 
Calderon F, Kim H-Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem  2004; 90(4): 979-88.
[http://dx.doi.org/10.1111/j.1471-4159.2004.02520.x] [PMID: 15287904] 
[64] 
Ahmad A, Moriguchi T, Salem N. Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatr Neurol  2002; 26(3): 210-8.
[http://dx.doi.org/10.1016/S0887-8994(01)00383-6] [PMID: 11955929] 
[65] 
Wurtman RJ, Cansev M, Ulus IH. Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides. J Nutr Health Aging  2009; 13(3): 189-97.
[http://dx.doi.org/10.1007/s12603-009-0056-3] [PMID: 19262950] 
[66] 
de Velasco PC, Mendonça HR, Borba JM, et al. Nutritional restriction of omega-3 fatty acids alters topographical fine tuning and leads to a delay in the critical period in the rodent visual system. Exp Neurol  2012; 234(1): 220-9.
[http://dx.doi.org/10.1016/j.expneurol.2011.12.032] [PMID: 22227060] 
[67] 
Georgieff MK, Innis SM. Controversial nutrients that potentially affect preterm neurodevelopment: essential fatty acids and iron. Pediatr Res  2005; 57(5 Pt 2): 99R-103R.
[http://dx.doi.org/10.1203/01.PDR.0000160542.69840.0F] [PMID: 15817493] 
[68] 
McNamara RK, Asch RH, Lindquist DM, Krikorian R. Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings. Prostaglandins Leukot Essent Fatty Acids  2018; 136: 23-34.
[http://dx.doi.org/10.1016/j.plefa.2017.05.001] [PMID: 28529008] 
[69] 
Grayson DS, Kroenke CD, Neuringer M, Fair DA. Dietary omega-3 fatty acids modulate large-scale systems organization in the rhesus macaque brain. J Neurosci  2014; 34(6): 2065-74.
[http://dx.doi.org/10.1523/JNEUROSCI.3038-13.2014] [PMID: 24501348] 
[70] 
Agostoni C. Role of long-chain polyunsaturated fatty acids in the first year of life. J Pediatr Gastroenterol Nutr  2008; 47(Suppl. 2): S41-4.
[http://dx.doi.org/10.1097/01.mpg.0000338811.52062.b2] [PMID: 18931599] 
[71] 
Neuringer M. Infant vision and retinal function in studies of dietary long-chain polyunsaturated fatty acids: methods, results, and implications. Am J Clin Nutr  2000; 71(1)(Suppl.): 256S-67S.
[http://dx.doi.org/10.1093/ajcn/71.1.256S] [PMID: 10617981] 
[72] 
Bourre JM, Durand G, Pascal G, Youyou A. Brain cell and tissue recovery in rats made deficient in n-3 fatty acids by alteration of dietary fat. J Nutr  1989; 119(1): 15-22.
[http://dx.doi.org/10.1093/jn/119.1.15] [PMID: 2563284] 
[73] 
Li D, Weisinger HS, Weisinger RS, et al. Omega 6 to omega 3 fatty acid imbalance early in life leads to persistent reductions in DHA levels in glycerophospholipids in rat hypothalamus even after long-term omega 3 fatty acid repletion. Prostaglandins Leukot Essent Fatty Acids  2006; 74(6): 391-9.
[http://dx.doi.org/10.1016/j.plefa.2006.03.010] [PMID: 16716580] 
[74] 
Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr  2011; 93(5): 950-62.
[http://dx.doi.org/10.3945/ajcn.110.006643] [PMID: 21367944] 
[75] 
Cutler GJ, Flood A, Hannan P, Neumark-Sztainer D. Major patterns of dietary intake in adolescents and their stability over time. J Nutr  2009; 139(2): 323-8.
[http://dx.doi.org/10.3945/jn.108.090928] [PMID: 19091799] 
[76] 
Svennerholm L. Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res  1968; 9: 570-9.
[77] 
Lisdahl KM, Gilbart ER, Wright NE, Shollenbarger S. Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry  2013; 4: 53.
[http://dx.doi.org/10.3389/fpsyt.2013.00053] [PMID: 23847550] 
[78] 
Wetherill RR, Squeglia LM, Yang TT, Tapert SF. A longitudinal examination of adolescent response inhibition: neural differences before and after the initiation of heavy drinking. Psychopharmacology (Berl)  2013; 230(4): 663-71.
[http://dx.doi.org/10.1007/s00213-013-3198-2] [PMID: 23832422] 
[79] 
Luciana M, Bjork JM, Nagel BJ, et al. Adolescent neurocognitive
 development and impacts of substance use: Overview of the adolescent
 brain cognitive development (ABCD) baseline neurocognition
 batteryDevelopmental Cognitive Neuroscience. Elsevier  2018; 32: 0167-9.
[http://dx.doi.org/10.1016/j.dcn.2018.02.006] 
[80] 
Fishbein DH, Rose EJ, Darcey VL, Belcher AM, VanMeter JW. Neurodevelopmental precursors and consequences of substance use during adolescence: Promises and pitfalls of longitudinal neuroimaging strategies. Front Hum Neurosci  2016; 10: 296.
[http://dx.doi.org/10.3389/fnhum.2016.00296] [PMID: 27445743] 
[81] 
Edalati H, Krank MD. Childhood maltreatment and development of substance use disorders: a review and a model of cognitive pathways. Trauma Violence Abuse  2016; 17(5): 454-67.
[http://dx.doi.org/10.1177/1524838015584370] [PMID: 25964275] 
[82] 
Rose EJ, Picci G, Fishbein DH. Neurocognitive precursors of substance misuse corresponding to risk, resistance, and resilience pathways: Implications for prevention science. Front Psychiatry  2019; 10: 399.
[http://dx.doi.org/10.3389/fpsyt.2019.00399] [PMID: 31258493] 
[83] 
Clay JM, Parker MO. The role of stress-reactivity, stress-recovery and risky decision-making in psychosocial stress-induced alcohol consumption in social drinkers. Psychopharmacology (Berl)  2018; 235(11): 3243-57.
[http://dx.doi.org/10.1007/s00213-018-5027-0] [PMID: 30209533] 
[84] 
Chaplin TM, Niehaus C, Gonçalves SF. Stress reactivity and the developmental psychopathology of adolescent substance use. Neurobiology of Stress Elsevier Inc   2018; 9: 01133-139.
[http://dx.doi.org/10.1016/j.ynstr.2018.09.002] 
[85] 
Koob GF. Brain stress systems in the amygdala and addiction. Brain Res  2009; 1293: 61-75.
[http://dx.doi.org/10.1016/j.brainres.2009.03.038] 
[86] 
Dawe S, Gullo MJ, Loxton NJ. Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse. Addict Behav  2004; 29(7): 1389-405.
[http://dx.doi.org/10.1016/j.addbeh.2004.06.004] [PMID: 15345272] 
[87] 
Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry  2001; 158(11): 1783-93.
[http://dx.doi.org/10.1176/appi.ajp.158.11.1783] [PMID: 11691682] 
[88] 
Evenden JL. Varieties of impulsivity. Psychopharmacology (Berl)  1999; 146(4): 348-61.
[http://dx.doi.org/10.1007/PL00005481] [PMID: 10550486] 
[89] 
Potenza MN, de Wit H. Control yourself: alcohol and impulsivity. Alcohol Clin Exp Res  2010; 34(8): 1303-5.
[PMID: 20491735] 
[90] 
Reynolds B, Ortengren A, Richards JB, de Wit H. Dimensions of impulsive behavior: Personality and behavioral measures. Pers Individ Dif  2006; 40(2): 305-15.
[http://dx.doi.org/10.1016/j.paid.2005.03.024] 
[91] 
de Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol  2009; 14(1): 22-31.
[http://dx.doi.org/10.1111/j.1369-1600.2008.00129.x] [PMID: 18855805] 
[92] 
Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci  2004; 24(49): 11017-22.
[http://dx.doi.org/10.1523/JNEUROSCI.3321-04.2004] [PMID: 15590917] 
[93] 
Lawrence AJ, Luty J, Bogdan NA, Sahakian BJ, Clark L. Impulsivity and response inhibition in alcohol dependence and problem gambling. Psychopharmacology (Berl)  2009; 207(1): 163-72.
[http://dx.doi.org/10.1007/s00213-009-1645-x] [PMID: 19727677] 
[94] 
Verdejo-García AJ, Perales JC, Pérez-García M. Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addict Behav  2007; 32(5): 950-66.
[http://dx.doi.org/10.1016/j.addbeh.2006.06.032] [PMID: 16876962] 
[95] 
Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET. Abnormal brain structure implicated in stimulant drug addiction. Science  2012; 335(6068): 601-4.
[http://dx.doi.org/10.1126/science.1214463] 
[96] 
Smith J L, Mattick R P, Jamadar S D, Iredale J M. Deficits in behavioural inhibition in substance abuse and addiction: A meta-analysisDrug and Alcohol Dependence  Elsevier  2014; 145: 011-33.
[http://dx.doi.org/10.1016/j.drugalcdep.2014.08.009] 
[97] 
Coffey SF, Gudleski GD, Saladin ME, Brady KT. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol  2003; 11(1): 18-25.
[http://dx.doi.org/10.1037/1064-1297.11.1.18] [PMID: 12622340] 
[98] 
Mole TB, et al. Impulsivity in disorders of food and drug misuse. Psychol Med  2014; 1-12.
[PMID: 25118940] 
[99] 
Moallem NR, Ray LA. Dimensions of impulsivity among heavy drinkers, smokers, and heavy drinking smokers: singular and combined effects. Addict Behav  2012; 37(7): 871-4.
[http://dx.doi.org/10.1016/j.addbeh.2012.03.002] [PMID: 22445419] 
[100] 
Williams BR, Ponesse JS, Schachar RJ, Logan GD, Tannock R. Development of inhibitory control across the life span. Dev Psychol  1999; 35(1): 205-13.
[http://dx.doi.org/10.1037/0012-1649.35.1.205] [PMID: 9923475] 
[101] 
Donnellan MB, Conger RD, Burzette RG. Personality development from late adolescence to young adulthood: differential stability, normative maturity, and evidence for the maturity-stability hypothesis. J Pers  2007; 75(2): 237-63.
[http://dx.doi.org/10.1111/j.1467-6494.2007.00438.x] [PMID: 17359238] 
[102] 
Diamond A. Executive functions. Annu Rev Psychol  2013; 64: 135-68.
[http://dx.doi.org/10.1146/annurev-psych-113011-143750] [PMID: 23020641] 
[103] 
Petersen IT, Hoyniak CP, McQuillan ME, Bates JE, Staples AD. Measuring the development of inhibitory control: The challenge of heterotypic continuity. Dev Rev  2016; 40: 25-71.
[http://dx.doi.org/10.1016/j.dr.2016.02.001] [PMID: 27346906] 
[104] 
Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev  2008; 32(4): 777-810.
[http://dx.doi.org/10.1016/j.neubiorev.2007.11.003] [PMID: 18295884] 
[105] 
Moeller SJ, Bederson L, Alia-Klein N, Goldstein RZ. Neuroscience of inhibition for addiction medicine: from prediction of initiation to prediction of relapse in Progress in Brain Research. Elsevier  2016; 223: 165-88.
[http://dx.doi.org/10.1016/bs.pbr.2015.07.007] 
[106] 
Nigg JT, Wong MM, Martel MM, et al. Poor response inhibition as a predictor of problem drinking and illicit drug use in adolescents at risk for alcoholism and other substance use disorders. J Am Acad Child Adolesc Psychiatry  2006; 45(4): 468-75.
[http://dx.doi.org/10.1097/01.chi.0000199028.76452.a9] [PMID: 16601652] 
[107] 
Peeters M, Oldehinkel T, Vollebergh W. Behavioral control and reward sensitivity in adolescents’ risk taking behavior: A longitudinal TRAILS study. Front Psychol  2017; 8(FEB): 231.
[http://dx.doi.org/10.3389/fpsyg.2017.00231] [PMID: 28261148] 
[108] 
Nees F, Tzschoppe J, Patrick CJ, et al. IMAGEN Consortium. Determinants of early alcohol use in healthy adolescents: the differential contribution of neuroimaging and psychological factors. Neuropsychopharmacology  2012; 37(4): 986-95.
[http://dx.doi.org/10.1038/npp.2011.282] [PMID: 22113088] 
[109] 
Whelan R, Conrod PJ, Poline JB, et al. IMAGEN Consortium. Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci  2012; 15(6): 920-5.
[http://dx.doi.org/10.1038/nn.3092] [PMID: 22544311] 
[110] 
Mahmood OM, Goldenberg D, Thayer R, Migliorini R, Simmons AN, Tapert SF. Adolescents’ fMRI activation to a response inhibition task predicts future substance use. Addict Behav  2013; 38(1): 1435-41.
[http://dx.doi.org/10.1016/j.addbeh.2012.07.012] [PMID: 23006248] 
[111] 
Norman AL, Pulido C, Squeglia LM, Spadoni AD, Paulus MP, Tapert SF. Neural activation during inhibition predicts initiation of substance use in adolescence. Drug Alcohol Depend  2011; 119(3): 216-23.
[http://dx.doi.org/10.1016/j.drugalcdep.2011.06.019] [PMID: 21782354] 
[112] 
Rao U, Sidhartha T, Harker KR, Bidesi AS, Chen LA, Ernst M. Relationship between adolescent risk preferences on a laboratory task and behavioral measures of risk-taking. J Adolesc Health  2011; 48(2): 151-8.
[http://dx.doi.org/10.1016/j.jadohealth.2010.06.008] [PMID: 21257113] 
[113] 
Fishbein DH, Eldreth DL, Hyde C, et al. Risky decision making and the anterior cingulate cortex in abstinent drug abusers and nonusers. Brain Res Cogn Brain Res  2005; 23(1): 119-36.
[http://dx.doi.org/10.1016/j.cogbrainres.2004.12.010] [PMID: 15795139] 
[114] 
Boog M, Goudriaan AE, Wetering BJ, Polak M, Deuss H, Franken IHA. Rash impulsiveness and reward sensitivity as predictors of treatment outcome in male substance dependent patients. Addict Behav  2014; 39(11): 1670-5.
[http://dx.doi.org/10.1016/j.addbeh.2014.02.020] [PMID: 24837083] 
[115] 
Steinberg L, Graham S, O’Brien L, Woolard J, Cauffman E, Banich M. Age differences in future orientation and delay discounting. Child Dev  2009; 80(1): 28-44.
[http://dx.doi.org/10.1111/j.1467-8624.2008.01244.x] [PMID: 19236391] 
[116] 
Smith DG, Xiao L, Bechara A. Decision making in children and adolescents: impaired Iowa Gambling Task performance in early adolescence. Dev Psychol  2012; 48(4): 1180-7.
[http://dx.doi.org/10.1037/a0026342] [PMID: 22081879] 
[117] 
Van Leijenhorst L, Westenberg PM, Crone EA. A developmental study of risky decisions on the cake gambling task: age and gender analyses of probability estimation and reward evaluation. Dev Neuropsychol  2008; 33(2): 179-96.
[http://dx.doi.org/10.1080/87565640701884287] [PMID: 18443976] 
[118] 
Hulvershorn LA, Hummer TA, Fukunaga R, et al. Neural activation during risky decision-making in youth at high risk for substance use disorders. Psychiatry Res  2015; 233(2): 102-11.
[http://dx.doi.org/10.1016/j.pscychresns.2015.05.007] [PMID: 26071624] 
[119] 
Bø R, Billieux J, Gjerde LC, Eilertsen EM, Landrø NI. Do executive functions predict binge-drinking patterns? Evidence from a longitudinal study in young adulthood. Front Psychol  2017; 8: 489.
[http://dx.doi.org/10.3389/fpsyg.2017.00489] [PMID: 28408897] 
[120] 
MacPherson L, Magidson JF, Reynolds EK, Kahler CW, Lejuez CW. Changes in sensation seeking and risk-taking propensity predict increases in alcohol use among early adolescents. Alcohol Clin Exp Res  2010; 34(8): 1400-8.
[http://dx.doi.org/10.1111/j.1530-0277.2010.01223.x] [PMID: 20491737] 
[121] 
Kim-Spoon J, Deater-Deckard K, Holmes C, Lee J, Chiu P, King-Casas B. Behavioral and neural inhibitory control moderates the effects of reward sensitivity on adolescent substance use. Neuropsychologia  2016; 91: 318-26.
[http://dx.doi.org/10.1016/j.neuropsychologia.2016.08.028] [PMID: 27580969] 
[122] 
Giedd JN, Blumenthal J, Jeffries NO, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci  1999; 2(10): 861-3.
[http://dx.doi.org/10.1038/13158] [PMID: 10491603] 
[123] 
Huttenlocher PR. Morphometric study of human cerebral cortex development. Neuropsychologia  1990; 28(6): 517-27.
[http://dx.doi.org/10.1016/0028-3932(90)90031-I] [PMID: 2203993] 
[124] 
Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci  2008; 9(12): 947-57.
[http://dx.doi.org/10.1038/nrn2513] [PMID: 19002191] 
[125] 
Gogtay N, Thompson PM. Mapping gray matter development: implications for typical development and vulnerability to psychopathology. Brain Cogn  2010; 72(1): 6-15.
[http://dx.doi.org/10.1016/j.bandc.2009.08.009] [PMID: 19796863] 
[126] 
Tamnes CK, Østby Y, Fjell AM, Westlye LT, Due-Tønnessen P, Walhovd KB. Brain maturation in adolescence and young adulthood: regional age-related changes in cortical thickness and white matter volume and microstructure. Cereb Cortex  2010; 20(3): 534-48.
[http://dx.doi.org/10.1093/cercor/bhp118] [PMID: 19520764] 
[127] 
Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA  2004; 101(21): 8174-9.
[http://dx.doi.org/10.1073/pnas.0402680101] [PMID: 15148381] 
[128] 
Remer J, Croteau-Chonka E, Dean DC III, et al. Quantifying cortical development in typically developing toddlers and young children, 1-6 years of age. Neuroimage  2017; 153: 246-61.
[http://dx.doi.org/10.1016/j.neuroimage.2017.04.010] [PMID: 28392489] 
[129] 
Shaw P, Kabani NJ, Lerch JP, et al. Neurodevelopmental trajectories of the human cerebral cortex. J Neurosci  2008; 28(14): 3586-94.
[http://dx.doi.org/10.1523/JNEUROSCI.5309-07.2008] [PMID: 18385317] 
[130] 
Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol  1997; 387(2): 167-78.
[http://dx.doi.org/10.1002/(SICI)1096-9861(19971020)387:2<167:AID-CNE1>3.0.CO;2-Z] [PMID: 9336221] 
[131] 
Sowell ER, Thompson PM, Leonard CM, Welcome SE, Kan E, Toga AW. Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci  2004; 24(38): 8223-31.
[http://dx.doi.org/10.1523/JNEUROSCI.1798-04.2004] [PMID: 15385605] 
[132] 
Casey BJ, Giedd JN, Thomas KM. Structural and functional brain development and its relation to cognitive development. Biol Psychol  2000; 54(1-3): 241-57.
[http://dx.doi.org/10.1016/S0301-0511(00)00058-2] [PMID: 11035225] 
[133] 
Rubia K, Smith AB, Taylor E, Brammer M. Linear age-correlated functional development of right inferior fronto-striato-cerebellar networks during response inhibition and anterior cingulate during error-related processes. Hum Brain Mapp  2007; 28(11): 1163-77.
[http://dx.doi.org/10.1002/hbm.20347] [PMID: 17538951] 
[134] 
Galvan A, Hare TA, Parra CE, et al. Earlier development of the accumbens relative to orbitofrontal cortex might underlie risk-taking behavior in adolescents. J Neurosci  2006; 26(25): 6885-92.
[http://dx.doi.org/10.1523/JNEUROSCI.1062-06.2006] [PMID: 16793895] 
[135] 
Steinberg L. A social neuroscience perspective on adolescent risk-taking. Dev Rev  2008; 28(1): 78-106.
[http://dx.doi.org/10.1016/j.dr.2007.08.002] [PMID: 18509515] 
[136] 
Meisel SN, Fosco WD, Hawk LW, Colder CR. Mind the gap: A review and recommendations for statistically evaluating Dual Systems models of adolescent risk behavior. Dev Cogn Neurosci  2019; 39: 100681
[http://dx.doi.org/10.1016/j.dcn.2019.100681] [PMID: 31404858] 
[137] 
Wang Q, Chen C, Cai Y, et al. Dissociated neural substrates underlying impulsive choice and impulsive action. Neuroimage  2016; 134: 540-9.
[http://dx.doi.org/10.1016/j.neuroimage.2016.04.010] [PMID: 27083527] 
[138] 
Andrews-Hanna JR, Mackiewicz Seghete KL, Claus ED, Burgess GC, Ruzic L, Banich MT. Cognitive control in adolescence: neural underpinnings and relation to self-report behaviors. PLoS One  2011; 6(6): e21598
[http://dx.doi.org/10.1371/journal.pone.0021598] [PMID: 21738725] 
[139] 
Tamm L, Menon V, Reiss AL. Maturation of brain function associated with response inhibition. J Am Acad Child Adolesc Psychiatry  2002; 41(10): 1231-8.
[http://dx.doi.org/10.1097/00004583-200210000-00013] [PMID: 12364845] 
[140] 
Christakou A, Brammer M, Rubia K. Maturation of limbic corticostriatal activation and connectivity associated with developmental changes in temporal discounting. Neuroimage  2011; 54(2): 1344-54.
[http://dx.doi.org/10.1016/j.neuroimage.2010.08.067] [PMID: 20816974] 
[141] 
Bunge SA, Dudukovic NM, Thomason ME, Vaidya CJ, Gabrieli JDE. Immature frontal lobe contributions to cognitive control in children: evidence from fMRI. Neuron  2002; 33(2): 301-11.
[http://dx.doi.org/10.1016/S0896-6273(01)00583-9] [PMID: 11804576] 
[142] 
Steinbeis N, Haushofer J, Fehr E, Singer T. Development of behavioral control and associated vmPFC-DLPFC connectivity explains children’s increased resistance to temptation in intertemporal choice. Cereb Cortex  2016; 26(1): 32-42.
[http://dx.doi.org/10.1093/cercor/bhu167] [PMID: 25100855] 
[143] 
Ordaz SJ, Foran W, Velanova K, Luna B. Longitudinal growth curves of brain function underlying inhibitory control through adolescence. J Neurosci  2013; 33(46): 18109-24.
[http://dx.doi.org/10.1523/JNEUROSCI.1741-13.2013] [PMID: 24227721] 
[144] 
Heitzeg MM, Nigg JT, Hardee JE, et al. Left middle frontal gyrus response to inhibitory errors in children prospectively predicts early problem substance use. Drug Alcohol Depend  2014; 141: 51-7.
[http://dx.doi.org/10.1016/j.drugalcdep.2014.05.002] [PMID: 24882366] 
[145] 
Whelan R, Watts R, Orr CA, et al. IMAGEN Consortium. Neuropsychosocial profiles of current and future adolescent alcohol misusers. Nature  2014; 512(7513): 185-9.
[http://dx.doi.org/10.1038/nature13402] [PMID: 25043041] 
[146] 
Galván A. The Teenage Brain. Curr Dir Psychol Sci  2013; 22(2): 88-93.
[http://dx.doi.org/10.1177/0963721413480859] 
[147] 
Sherman L, Steinberg L, Chein J. Connecting brain responsivity
 and real-world risk taking: Strengths and limitations of current
 methodological approaches. Developmental Cognitive Neuroscience Elsevier  2018; 33: 0127-41.
[http://dx.doi.org/10.1016/j.dcn.2017.05.007] 
[148] 
Van Leijenhorst L, Gunther Moor B, Op de Macks ZA, Rombouts SARB, Westenberg PM, Crone EA. Adolescent risky decision-making: neurocognitive development of reward and control regions. Neuroimage  2010; 51(1): 345-55.
[http://dx.doi.org/10.1016/j.neuroimage.2010.02.038] [PMID: 20188198] 
[149] 
Shad MU, Bidesi AS, Chen L-A, Thomas BP, Ernst M, Rao U. Neurobiology of decision-making in adolescents. Behav Brain Res  2011; 217(1): 67-76.
[http://dx.doi.org/10.1016/j.bbr.2010.09.033] [PMID: 20933020] 
[150] 
Eshel N, Nelson EE, Blair RJ, Pine DS, Ernst M. Neural substrates of choice selection in adults and adolescents: development of the ventrolateral prefrontal and anterior cingulate cortices. Neuropsychologia  2007; 45(6): 1270-9.
[http://dx.doi.org/10.1016/j.neuropsychologia.2006.10.004] [PMID: 17118409] 
[151] 
Ernst M, Nelson EE, Jazbec S, et al. Amygdala and nucleus accumbens in responses to receipt and omission of gains in adults and adolescents. Neuroimage  2005; 25(4): 1279-91.
[http://dx.doi.org/10.1016/j.neuroimage.2004.12.038] [PMID: 15850746] 
[152] 
Geier CF, Terwilliger R, Teslovich T, Velanova K, Luna B. Immaturities in reward processing and its influence on inhibitory control in adolescence. Cereb Cortex  2010; 20(7): 1613-29.
[http://dx.doi.org/10.1093/cercor/bhp225] [PMID: 19875675] 
[153] 
Stice E, Yokum S, Burger KS. Elevated reward region responsivity predicts future substance use onset but not overweight/obesity onset. Biol Psychiatry  2013; 73(9): 869-76.
[http://dx.doi.org/10.1016/j.biopsych.2012.11.019] [PMID: 23312561] 
[154] 
Brumback TY, Worley M, Nguyen-Louie TT, Squeglia LM, Jacobus J, Tapert SF. Neural predictors of alcohol use and psychopathology symptoms in adolescents. Dev Psychopathol  2016; 28(4pt1): 1209-16.
[http://dx.doi.org/10.1017/S0954579416000766] [PMID: 27739397] 
[155] 
Cheetham A, Allen NB, Whittle S, Simmons J, Yücel M, Lubman DI. Volumetric differences in the anterior cingulate cortex prospectively predict alcohol-related problems in adolescence. Psychopharmacology (Berl)  2014; 231(8): 1731-42.
[http://dx.doi.org/10.1007/s00213-014-3483-8] [PMID: 24553579] 
[156] 
Becker B, Wagner D, Koester P, et al. Smaller amygdala and medial prefrontal cortex predict escalating stimulant use. Brain  2015; 138(Pt 7): 2074-86.
[http://dx.doi.org/10.1093/brain/awv113] [PMID: 25971784] 
[157] 
Urošević S, Collins P, Muetzel R, Schissel A, Lim KO, Luciana M. Effects of reward sensitivity and regional brain volumes on substance use initiation in adolescence. Soc Cogn Affect Neurosci  2015; 10(1): 106-13.
[http://dx.doi.org/10.1093/scan/nsu022] [PMID: 24526186] 
[158] 
Squeglia LM, Cservenka A. Adolescence and drug use vulnerability: Findings from neuroimaging. Curr Opin Behav Sci  2017; 13: 164-70.
[http://dx.doi.org/10.1016/j.cobeha.2016.12.005] [PMID: 28111629] 
[159] 
Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr  2007; 137(4): 855-9.
[http://dx.doi.org/10.1093/jn/137.4.855] [PMID: 17374644] 
[160] 
Darios F, Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature  2006; 440(7085): 813-7.
[http://dx.doi.org/10.1038/nature04598] [PMID: 16598260] 
[161] 
Pongrac JL, Slack PJ, Innis SM. Dietary polyunsaturated fat that is low in (n-3) and high in (n-6) fatty acids alters the SNARE protein complex and nitrosylation in rat hippocampus. J Nutr  2007; 137(8): 1852-6.
[http://dx.doi.org/10.1093/jn/137.8.1852] [PMID: 17634254] 
[162] 
Sidhu VK, Huang BX, Kim HY. Effects of docosahexaenoic acid on mouse brain synaptic plasma membrane proteome analyzed by mass spectrometry and (16)O/(18)O labeling. J Proteome Res  2011; 10(12): 5472-80.
[http://dx.doi.org/10.1021/pr2007285] [PMID: 22003853] 
[163] 
Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr  2012; 142(3): 592S-9S.
[http://dx.doi.org/10.3945/jn.111.155259] [PMID: 22279140] 
[164] 
Salem N Jr, Litman B, Kim HY, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids  2001; 36(9): 945-59.
[http://dx.doi.org/10.1007/s11745-001-0805-6] [PMID: 11724467] 
[165] 
Heron DS, Shinitzky M, Hershkowitz M, Samuel D. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci USA  1980; 77(12 II): 7463-.
[http://dx.doi.org/10.1073/pnas.77.12.7463] 
[166] 
Paila YD, Ganguly S, Chattopadhyay A. Metabolic depletion of sphingolipids impairs ligand binding and signaling of human serotonin1A receptors. Biochemistry  2010; 49(11): 2389-97.
[http://dx.doi.org/10.1021/bi1001536] [PMID: 20170167] 
[167] 
Jones CR, Arai T, Rapoport SI. Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. Neurochem Res  1997; 22(6): 663-70.
[http://dx.doi.org/10.1023/A:1027341707837] [PMID: 9178948] 
[168] 
Murphy MG. Dietary fatty acids and membrane protein function. J Nutr Biochem  1990; 1(2): 68-79.
[http://dx.doi.org/10.1016/0955-2863(90)90052-M] [PMID: 15539188] 
[169] 
Wainwright PE, Xing H-C, Girard T, Parker L, Ward GR. Effects of dietary n-3 fatty acid deficiency on morris water-maze performance and amphetamine-induced conditioned place preference in rats. Nutr Neurosci  1998; 1(4): 281-93.
[http://dx.doi.org/10.1080/1028415X.1998.11747238] [PMID: 27414697] 
[170] 
Vancassel S, Blondeau C, Lallemand S, et al. Hyperactivity in the rat is associated with spontaneous low level of n-3 polyunsaturated fatty acids in the frontal cortex. Behav Brain Res  2007; 180(2): 119-26.
[http://dx.doi.org/10.1016/j.bbr.2007.02.032] [PMID: 17397943] 
[171] 
Levant B, Zarcone TJ, Fowler SC. Developmental effects of dietary n-3 fatty acids on activity and response to novelty. Physiol Behav  2010; 101(1): 176-83.
[http://dx.doi.org/10.1016/j.physbeh.2010.04.038] [PMID: 20457171] 
[172] 
Baladi MG, Koek W, Aumann M, Velasco F, France CP. Eating high fat chow enhances the locomotor-stimulating effects of cocaine in adolescent and adult female rats. Psychopharmacology (Berl)  2012; 222(3): 447-57.
[http://dx.doi.org/10.1007/s00213-012-2663-7] [PMID: 22418731] 
[173] 
Kuhn FT, Trevizol F, Dias VT, et al. Toxicological aspects of trans fat consumption over two sequential generations of rats: Oxidative damage and preference for amphetamine. Toxicol Lett  2015; 232(1): 58-67.
[http://dx.doi.org/10.1016/j.toxlet.2014.10.001] [PMID: 25290576] 
[174] 
Serafine KM, Labay C, France CP. Dietary supplementation with fish oil prevents high fat diet-induced enhancement of sensitivity to the locomotor stimulating effects of cocaine in adolescent female rats. Drug Alcohol Depend  2016; 165: 45-52.
[http://dx.doi.org/10.1016/j.drugalcdep.2016.05.013] [PMID: 27242289] 
[175] 
Bernardi RE, Spanagel R. Basal activity level in mice predicts the initial and sensitized locomotor response to nicotine only in high responders. Behav Brain Res  2014; 264: 143-50.
[http://dx.doi.org/10.1016/j.bbr.2014.01.046] [PMID: 24508239] 
[176] 
González-Marín MDC, Coune F, Naassila M. Vulnerability to ethanol sensitization predicts higher intake and motivation to self-administer ethanol: Proof of the incentive salience sensitization theory? Addict Biol 2019.: e12833
[http://dx.doi.org/10.1111/adb.12833] [PMID: 31762127] 
[177] 
Hernandez-Casner C, Woloshchuk CJ, Poisson C, Hussain S, Ramos J, Serafine KM. Dietary supplementation with fish oil reverses high fat diet-induced enhanced sensitivity to the behavioral effects of quinpirole. Behav Pharmacol  2019; 30(4): 370-5.
[http://dx.doi.org/10.1097/FBP.0000000000000439] [PMID: 31085944] 
[178] 
Trevizol F, Benvegnú DM, Barcelos RC, et al. Comparative study between n-6, trans and n-3 fatty acids on repeated amphetamine exposure: a possible factor for the development of mania. Pharmacol Biochem Behav  2011; 97(3): 560-5.
[http://dx.doi.org/10.1016/j.pbb.2010.11.004] [PMID: 21078338] 
[179] 
Chen C, Schultz J, Haven S, Schuebel K, Hibbeln J. Dietary lowering
 of omega-6 polyunsaturated fatty acids lowered voluntary ethanol
 binge-drinking in mice (OR19-02-19) Elsevier  2019; 3(Suppl.1): -.
[http://dx.doi.org/10.1093/cdn/nzz046.OR19-02-19] 
[180] 
Wolstenholme JT, Bowers MS, Pais AB, et al. Dietary omega-3 fatty acids differentially impact acute ethanol-responsive behaviors and ethanol consumption in DBA/2J versus C57BL/6J Mice. Alcohol Clin Exp Res  2018; 42(8): 1476-85.
[http://dx.doi.org/10.1111/acer.13780] [PMID: 29786878] 
[181] 
Hakimian J, Minasyan A, Zhe-Ying L, et al. Specific behavioral and cellular adaptations induced by chronic morphine are reduced by dietary omega-3 polyunsaturated fatty acids. PLoS One  2017; 12(4): e0175090
[http://dx.doi.org/10.1371/journal.pone.0175090] [PMID: 28380057] 
[182] 
Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci  2010; 13(5): 635-41.
[http://dx.doi.org/10.1038/nn.2519] [PMID: 20348917] 
[183] 
Kodas E, Vancassel S, Lejeune B, Guilloteau D, Chalon S. Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage. J Lipid Res  2002; 43(8): 1209-19.
[http://dx.doi.org/10.1194/jlr.M200132-JLR200] [PMID: 12177165] 
[184] 
Zimmer L, Durand G, Guilloteau D, Chalon S. n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex. Lipids  1999; 34(S1)(Suppl.): S251-1.
[http://dx.doi.org/10.1007/BF02562309] [PMID: 10419169] 
[185] 
Kuperstein F, Yakubov E, Dinerman P, et al. Overexpression of dopamine receptor genes and their products in the postnatal rat brain following maternal n-3 fatty acid dietary deficiency. J Neurochem  2005; 95(6): 1550-62.
[http://dx.doi.org/10.1111/j.1471-4159.2005.03513.x] [PMID: 16305626] 
[186] 
Metz VG, Segat HJ, Dias VT, et al. Omega-3 decreases D1 and D2 receptors expression in the prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats. J Nutr Biochem  2019; 67: 182-9.
[http://dx.doi.org/10.1016/j.jnutbio.2019.02.007] [PMID: 30951972] 
[187] 
South T, Huang XF. High-fat diet exposure increases dopamine D2 receptor and decreases dopamine transporter receptor binding density in the nucleus accumbens and caudate putamen of mice. Neurochem Res  2008; 33(3): 598-605.
[http://dx.doi.org/10.1007/s11064-007-9483-x] [PMID: 17940894] 
[188] 
Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet  2001; 357(9253): 354-7.
[http://dx.doi.org/10.1016/S0140-6736(00)03643-6] [PMID: 11210998] 
[189] 
Guo J, Simmons WK, Herscovitch P, Martin A, Hall KD. Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior. Mol Psychiatry  2014; 19(10): 1078-84.
[http://dx.doi.org/10.1038/mp.2014.102] [PMID: 25199919] 
[190] 
Horstmann A, Fenske WK, Hankir MK. Argument for a non-linear relationship between severity of human obesity and dopaminergic tone. Obes Rev  2015; 16(10): 821-30.
[http://dx.doi.org/10.1111/obr.12303] [PMID: 26098597] 
[191] 
Alsiö J, Olszewski PK, Norbäck AH, et al. Dopamine D1 receptor gene expression decreases in the nucleus accumbens upon long-term exposure to palatable food and differs depending on diet-induced obesity phenotype in rats. Neuroscience  2010; 171(3): 779-87.
[http://dx.doi.org/10.1016/j.neuroscience.2010.09.046] [PMID: 20875839] 
[192] 
Speed N, Saunders C, Davis AR, et al. Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. PLoS One  2011; 6(9): e25169
[http://dx.doi.org/10.1371/journal.pone.0025169] [PMID: 21969871] 
[193] 
Cone JJ, Chartoff EH, Potter DN, Ebner SR, Roitman MF. Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. PLoS One  2013; 8(3): e58251
[http://dx.doi.org/10.1371/journal.pone.0058251] [PMID: 23516454] 
[194] 
Oginsky MF, Santana-rodriguez Z, Ferrario CR. Insulin enhances presynaptic glutamate release in the nucleus accumbens via opioid receptor-mediated disinhibition. bioRxiv 2019.
[http://dx.doi.org/10.1101/517797] 
[195] 
Vollbrecht PJ, Mabrouk OS, Nelson AD, Kennedy RT, Ferrario CR. Pre-existing differences and diet-induced alterations in striatal dopamine systems of obesity-prone rats. Obesity (Silver Spring)  2016; 24(3): 670-7.
[http://dx.doi.org/10.1002/oby.21411] [PMID: 26847484] 
[196] 
Delion S, Chalon S, Hérault J, Guilloteau D, Besnard JC, Durand G. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr  1994; 124(12): 2466-76.
[197] 
Zimmer L, Breton P, Durand G, Guilloteau D, Besnard JC, Chalon S. Prominent role of n-3 polyunsaturated fatty acids in cortical dopamine metabolism. Nutr Neurosci  1999; 2(4): 257-65.
[http://dx.doi.org/10.1080/1028415X.1999.11747282] [PMID: 27415577] 
[198] 
Levant B, Radel JD, Carlson SE. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav Brain Res  2004; 152(1): 49-57.
[PMID: 15135968] 
[199] 
Pimentel GD, Lira FS, Rosa JC, et al. High-fat fish oil diet prevents hypothalamic inflammatory profile in rats. ISRN Inflamm  2013; 2013: 419823
[http://dx.doi.org/10.1155/2013/419823] [PMID: 24049658] 
[200] 
Vonder Haar C, Ferland JN, Kaur S, Riparip LK, Rosi S, Winstanley CA. Cocaine self-administration is increased after frontal traumatic brain injury and associated with neuroinflammation. Eur J Neurosci  2019; 50(3): 2134-45.
[http://dx.doi.org/10.1111/ejn.14123] [PMID: 30118561] 
[201] 
Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB  2015; 29(6): 2207-22.
[http://dx.doi.org/10.1096/fj.14-268342] 
[202] 
Thomsen WJ, Grottick AJ, Menzaghi F, et al. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther  2008; 325(2): 577-87.
[http://dx.doi.org/10.1124/jpet.107.133348] [PMID: 18252809] 
[203] 
Higgins GA, Desnoyer J, Van Niekerk A, et al. Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity. Pharmacol Res Perspect  2015; 3(1): e00084
[http://dx.doi.org/10.1002/prp2.84] [PMID: 25692009] 
[204] 
Tak YJ, Lee SY. Anti-obesity drugs: long-term efficacy and safety: an updated review. World J Mens Health  2020; 38 Epub ahead of print
[http://dx.doi.org/10.5534/wjmh.200010] [PMID: 32202085] 
[205] 
Shanahan WR, Rose JE, Glicklich A, Stubbe S, Sanchez-Kam M. Lorcaserin for smoking cessation and associated weight gain: A randomized 12-week clinical trial. Nicotine Tob Res  2017; 19(8): 944-51.
[PMID: 27815511] 
[206] 
Higgins GA, Silenieks LB, Rossmann A, et al. The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control. Neuropsychopharmacology  2012; 37(5): 1177-91.
[http://dx.doi.org/10.1038/npp.2011.303] [PMID: 22189292] 
[207] 
Gerak LR, Collins GT, France CP. Effects of lorcaserin on cocaine and methamphetamine self-administration and reinstatement of responding previously maintained by cocaine in rhesus monkeys. J Pharmacol Exp Ther  2016; 359(3): 383-91.
[http://dx.doi.org/10.1124/jpet.116.236307] [PMID: 27650954] 
[208] 
Collins GT, Gerak LR, Javors MA, France CP. Lorcaserin reduces the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther  2016; 356(1): 85-95.
[http://dx.doi.org/10.1124/jpet.115.228833] [PMID: 26534942] 
[209] 
Banks ML, Negus SS. Repeated 7-Day treatment with the 5-HT2C agonist lorcaserin or the 5-ht2a antagonist pimavanserin alone or in combination fails to reduce cocaine vs food choice in male rhesus monkeys. Neuropsychopharmacology  2017; 42(5): 1082-92.
[http://dx.doi.org/10.1038/npp.2016.259] [PMID: 27857126] 
[210] 
Anker JJ, Carroll ME. Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci  2011; 8: 73-96.
[http://dx.doi.org/10.1007/7854_2010_93] [PMID: 21769724] 
[211] 
Dervola KS, Roberg BA, Wøien G, et al. Marine Ο-3 polyunsaturated fatty acids induce sex-specific changes in reinforcer-controlled behaviour and neurotransmitter metabolism in a spontaneously hypertensive rat model of ADHD. Behav Brain Funct  2012; 8(1): 56.
[http://dx.doi.org/10.1186/1744-9081-8-56] [PMID: 23228189] 
[212] 
Hernandez-Casner C, Ramos J, Serafine KM. Dietary supplementation with fish oil prevents high fat diet-induced enhancement of sensitivity to the behavioral effects of quinpirole. Behav Pharmacol  2017; 28(6): 477-84.
[http://dx.doi.org/10.1097/FBP.0000000000000322] [PMID: 28574870] 
[213] 
Kitson AP, Stroud CK, Stark KD. Elevated production of docosahexaenoic acid in females: potential molecular mechanisms. Lipids  2010; 45(3): 209-24.
[http://dx.doi.org/10.1007/s11745-010-3391-6] [PMID: 20151220] 
[214] 
Marra CA, de Alaniz MJ. Influence of testosterone administration on the biosynthesis of unsaturated fatty acids in male and female rats. Lipids  1989; 24(12): 1014-9.
[http://dx.doi.org/10.1007/BF02544071] [PMID: 2615569] 
[215] 
Crowe FL, Skeaff CM, Green TJ, Gray AR. Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. Br J Nutr  2008; 99(1): 168-74.
[http://dx.doi.org/10.1017/S000711450779387X] [PMID: 17678566] 
[216] 
Darcey VL, McQuaid GA, Fishbein DH, VanMeter JW. Relationship between whole blood omega-3 fatty acid levels and dorsal cingulate gray matter volume: Sex differences and implications for impulse control. Nutr Neurosci  2018; 8305: 1-11.
[http://dx.doi.org/10.1080/1028415X.2018.1525477] [PMID: 30264666] 
[217] 
Stevens LJ, Zentall SS, Deck JL, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr  1995; 62(4): 761-8.
[http://dx.doi.org/10.1093/ajcn/62.4.761] [PMID: 7572706] 
[218] 
Darcey VL, McQuaid GA, Fishbein DH, VanMeter JW. Dietary long-chain omega-3 fatty acids are related to impulse control and anterior cingulate function in adolescents. Front Neurosci  2019; 12: 1012.
[http://dx.doi.org/10.3389/fnins.2018.01012] [PMID: 30686978] 
[219] 
Gispert-Llaurado M, Perez-Garcia M, Escribano J, et al. EU Childhood Obesity Trial (CHOP) Study Group; NUHEAL Study Group. Fish consumption in mid-childhood and its relationship to neuropsychological outcomes measured in 7-9 year old children using a NUTRIMENTHE neuropsychological battery. Clin Nutr  2016; 35(6): 1301-7.
[http://dx.doi.org/10.1016/j.clnu.2016.02.008] [PMID: 26968967] 
[220] 
Robinson SL, Oliveros H, Mora-Plazas M, Marín C, Lozoff B, Villamor E. Polyunsaturated fatty acids in middle childhood and externalizing and internalizing behavior problems in adolescence. Eur J Clin Nutr  2019; 74(3): 481-90.
[PMID: 31383976] 
[221] 
Conklin SM, Harris JI, Manuck SB, Yao JK, Hibbeln JR, Muldoon MF. Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. Psychiatry Res  2007; 152(1): 1-10.
[http://dx.doi.org/10.1016/j.psychres.2006.10.006] [PMID: 17383013] 
[222] 
de Groot RHM, Hornstra G, Jolles J. Exploratory study into the relation between plasma phospholipid fatty acid status and cognitive performance. Prostaglandins Leukot Essent Fatty Acids  2007; 76(3): 165-72.
[http://dx.doi.org/10.1016/j.plefa.2007.01.001] [PMID: 17317131] 
[223] 
Silva V, Barazzoni R, Singer P. Biomarkers of fish oil omega-3 polyunsaturated fatty acids intake in humans. Nutr Clin Pract  2014; 29(1): 63-72.
[http://dx.doi.org/10.1177/0884533613516144] [PMID: 24336525] 
[224] 
Almeida DM, Jandacek RJ, Weber WA, McNamara RK. Docosahexaenoic acid biostatus is associated with event-related functional connectivity in cortical attention networks of typically developing children. Nutr Neurosci  2017; 20(4): 246-54.
[http://dx.doi.org/10.1179/1476830515Y.0000000046] [PMID: 26463682] 
[225] 
Barkley RA. Executive functions: What they are, how they work, and why they evolved. Guilford Press 2012.
[226] 
McNamara RK, Able J, Jandacek R, et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr  2010; 91(4): 1060-7.
[http://dx.doi.org/10.3945/ajcn.2009.28549] [PMID: 20130094] 
[227] 
McNamara RK, Jandacek R, Tso P, et al. Low docosahexaenoic acid status is associated with reduced indices in cortical integrity in the anterior cingulate of healthy male children: a 1H MRS Study. Nutr Neurosci  2013; 16(4): 183-90.
[http://dx.doi.org/10.1179/1476830512Y.0000000045] [PMID: 23582513] 
[228] 
Conklin SM, Gianaros PJ, Brown SM, et al. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett  2007; 421(3): 209-12.
[http://dx.doi.org/10.1016/j.neulet.2007.04.086] [PMID: 17574755] 
[229] 
Weaver CM, Miller JW. Challenges in conducting clinical nutrition research. Nutr Rev  2017; 75(7): 491-9.
[http://dx.doi.org/10.1093/nutrit/nux026] [PMID: 28605476] 
[230] 
Conrod PJ, Castellanos N, Mackie C. Personality-targeted interventions delay the growth of adolescent drinking and binge drinking. J Child Psychol Psychiatry  2008; 49(2): 181-90.
[PMID: 18211277] 
[231] 
Kalbag A S, Levin F R. Adult ADHD and substance abuse: Diagnostic
 and treatment issues. Substance Use and Misuse  2005 Dec; 40(13-14.): 1955-81.
[http://dx.doi.org/10.1080/10826080500294858] 
[232] 
Chang JPC, Su KP, Mondelli V, Pariante CM. Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: A systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology 2018. Nature Publishing Group  2018; 43(3): 534-45.
[http://dx.doi.org/10.1038/npp.2017.160] 
[233] 
Sonuga-Barke EJ, Holtmann M, Stevenson J, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American J Psychiatry  2013; 170(3): 275-89.
[http://dx.doi.org/10.1176/appi.ajp.2012.12070991] 
[234] 
Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry  2011; 50(10): 991-1000.
[http://dx.doi.org/10.1016/j.jaac.2011.06.008] [PMID: 21961774] 
[235] 
Kean JD, Sarris J, Scholey A, Silberstein R, Downey LA, Stough C. Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl)  2017; 234(3): 403-20.
[http://dx.doi.org/10.1007/s00213-016-4471-y] [PMID: 27921139] 
[236] 
Bos DJ, Oranje B, Veerhoek ES, et al. Reduced symptoms of inattention after dietary omega-3 fatty acid supplementation in boys with and without attention deficit/hyperactivity disorder. Neuropsychopharmacology  2015; 40(10): 2298-306.
[http://dx.doi.org/10.1038/npp.2015.73] [PMID: 25790022] 
[237] 
Vesco AT, Young AS, Arnold LE, Fristad MA. Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials. J Child Psychol Psychiatry  2018; 59(6): 628-36.
[http://dx.doi.org/10.1111/jcpp.12830] [PMID: 29063592] 
[238] 
Raine A, Portnoy J, Liu J, Mahoomed T, Hibbeln JR. Reduction in behavior problems with omega-3 supplementation in children aged 8-16 years: a randomized, double-blind, placebo-controlled, stratified, parallel-group trial. J Child Psychol Psychiatry  2015; 56(5): 509-20.
[http://dx.doi.org/10.1111/jcpp.12314] [PMID: 25146492] 
[239] 
Kirby A, Woodward A, Jackson S, Wang Y, Crawford MA. A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population. Res Dev Disabil  2010; 31(3): 718-30.
[http://dx.doi.org/10.1016/j.ridd.2010.01.014] [PMID: 20171055] 
[240] 
Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L. Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest  2005; 35(11): 691-9.
[http://dx.doi.org/10.1111/j.1365-2362.2005.01570.x] [PMID: 16269019] 
[241] 
Rogers PJ, Appleton KM, Kessler D, et al. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr  2008; 99(2): 421-31.
[http://dx.doi.org/10.1017/S0007114507801097] [PMID: 17956647] 
[242] 
Leckie RL, Lehman DE, Gianaros PJ, et al. The effects of omega-3 fatty acids on neuropsychological functioning and brain morphology in mid-life adults: a randomized clinical trial. Psychol Med  2019; 1-10.
[http://dx.doi.org/10.1017/S0033291719002617] [PMID: 31581959] 
[243] 
Ginty AT, Muldoon MF, Kuan DCH, et al. Omega-3 supplementation and the neural correlates of negative affect and impulsivity: A double-blind, randomized, placebo-controlled trial in midlife adults. Psychosom Med  2017; 79(5): 549-56.
[http://dx.doi.org/10.1097/PSY.0000000000000453] [PMID: 28121722] 
[244] 
Kuratko CN, Barrett EC, Nelson EB, Salem N Jr. The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: a review. Nutrients  2013; 5(7): 2777-810.
[http://dx.doi.org/10.3390/nu5072777] [PMID: 23877090] 
[245] 
Prior PL, Ramos AC, Eserian JK, Zaparoli J, Galduroz JCF. laxseed
 oil decreases craving for chocolate: Preliminary results Int
 Arch Addict Res Med  2015; 1(2)
[http://dx.doi.org/10.23937/2474-3631/1510010] 
[246] 
Stonehouse W. Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials. Nutrients Multidisciplinary Digital Publishing Institute  2014; 6(7): 2730-58.
[http://dx.doi.org/10.3390/nu6072730] 
[247] 
Hoenig C, Kuhn C, Benvegnú DM. Nutritional status and consumption of omega-3 fatty acids by substance abusers in recovery. J Psychiatry Ment Disord  2018; 3(1): 1008.
[248] 
Pawlosky RJ, Salem N Jr. Alcohol consumption in rhesus monkeys depletes tissues of polyunsaturated fatty acids and alters essential fatty acid metabolism. Alcohol Clin Exp Res  1999; 23(2): 311-7.
[http://dx.doi.org/10.1111/j.1530-0277.1999.tb04115.x] [PMID: 10069561] 
[249] 
Pawlosky RJ, Bacher J, Salem N Jr. Ethanol consumption alters electroretinograms and depletes neural tissues of docosahexaenoic acid in rhesus monkeys: nutritional consequences of a low n-3 fatty acid diet. Alcohol Clin Exp Res  2001; 25(12): 1758-65.
[http://dx.doi.org/10.1111/j.1530-0277.2001.tb02187.x] [PMID: 11781509] 
[250] 
Nervi AM, Peluffo RO, Brenner RR, Leikin AI. Effect of ethanol administration on fatty acid desaturation. Lipids  1980; 15(4): 263-8.
[http://dx.doi.org/10.1007/BF02535837] [PMID: 7374380] 
[251] 
Murff HJ, Tindle HA, Shrubsole MJ, et al. Smoking and red blood cell phospholipid membrane fatty acids. Prostaglandins Leukot Essent Fatty Acids  2016; 112: 24-31.
[http://dx.doi.org/10.1016/j.plefa.2016.08.004] [PMID: 27637337] 
[252] 
Volkow ND, Fowler JS, Wang G-J, Swanson JM, Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol  2007; 64(11): 1575-9.
[http://dx.doi.org/10.1001/archneur.64.11.1575] [PMID: 17998440] 
[253] 
Blum K, Braverman ER, Holder JM, et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs  2000; 32(Suppl.): i-iv, 1-112.
[http://dx.doi.org/10.1080/02791072.2000.10736099] [PMID: 11280926] 
[254] 
Hibbeln JR, Linnoila M, Umhau JC, Rawlings R, George DT, Salem N Jr. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry  1998; 44(4): 235-42.
[http://dx.doi.org/10.1016/S0006-3223(98)00141-3] [PMID: 9715354] 
[255] 
Buydens-Branchey L, Branchey M, McMakin DL, Hibbeln JR. Polyunsaturated fatty acid status and relapse vulnerability in cocaine addicts. Psychiatry Res  2003; 120(1): 29-35.
[http://dx.doi.org/10.1016/S0165-1781(03)00168-9] [PMID: 14500111] 
[256] 
Buydens-Branchey L, Branchey M, Hibbeln JR. Low plasma levels of docosahexaenoic acid are associated with an increased relapse vulnerability in substance abusers. Am J Addict  2009; 18(1): 73-80.
[http://dx.doi.org/10.1080/10550490802544003] [PMID: 19219668] 
[257] 
Rabinovitz S. Effects of omega-3 fatty acids on tobacco craving in cigarette smokers: A double-blind, randomized, placebo-controlled pilot study. J Psychopharmacol (Oxford)  2014; 28(8): 804-9.
[http://dx.doi.org/10.1177/0269881114536477] [PMID: 24899596] 
[258] 
Sadeghi-Ardekani K, Haghighi M, Zarrin R. Effects of omega-3 fatty acid supplementation on cigarette craving and oxidative stress index in heavy-smoker males: A double-blind, randomized, placebo-controlled clinical trial. J Psychopharmacol (Oxford)  2018; 32(9): 995-1002.
[http://dx.doi.org/10.1177/0269881118788806] [PMID: 30136619] 
[259] 
Borsonelo EC, Galduróz JCF. The role of polyunsaturated fatty acids (PUFAs) in development, aging and substance abuse disorders: review and propositions. Prostaglandins Leukot Essent Fatty Acids  2008; 78(4-5): 237-45.
[http://dx.doi.org/10.1016/j.plefa.2008.03.005] [PMID: 18502631] 
[260] 
Fogaça MN, Santos-Galduróz RF, Eserian JK, Galduróz JCF. The effects of polyunsaturated fatty acids in alcohol dependence treatment--a double-blind, placebo-controlled pilot study. BMC Clin Pharmacol  2011; 11(1): 10.
[http://dx.doi.org/10.1186/1472-6904-11-10] [PMID: 21787433] 
[261] 
Glen I, MacDonnell L, Glen E, MacKenzie J. “Possible pharmacologic approaches to the prevention and treatment of alcohol-related CNS impairment: Results of a double blind trial of essential fatty acid,” in pharmacological treatments for alcoholism.  London: Crooms-Helm 1984; pp. 331-50.
[262] 
Bozzatello P, Brignolo E, De Grandi E, Bellino S. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data. J Clin Med  2016; 5(8): 67.
[http://dx.doi.org/10.3390/jcm5080067] [PMID: 27472373] 
[263] 
Prado EL, Dewey KG. Nutrition and brain development in early life. Nutr Rev  2014; 72(4): 267-84.
[http://dx.doi.org/10.1111/nure.12102] [PMID: 24684384] 
[264] 
Martins VJ B, do Carmo P Franco M, Martins PA, et al. Long-lasting effects of undernutrition. Int J Environ Res Public Health  2011; 8(6): 1817-46.
[265] 
Bhattacharya J, Currie J, Haider S. Poverty, food insecurity, and nutritional outcomes in children and adults. J Health Econ  2004; 23(4): 839-62.
[http://dx.doi.org/10.1016/j.jhealeco.2003.12.008] [PMID: 15587700] 
[266] 
Baladi MG, Horton RE, Owens WA, Daws LC, France CP. Eating high fat chow decreases dopamine clearance in adolescent and adult male rats but selectively enhances the locomotor stimulating effects of cocaine in adolescents. Int J Neuropsychopharmacol  2015; 18(7): pyv024
[http://dx.doi.org/10.1093/ijnp/pyv024] [PMID: 25805560] 
[267] 
Lichtenstein A H, et al. Diet and lifestyle recommendations revision 2006 a scientific statement from the american heart association nutrition committee 2006.
[268] 
Lovegrove C, Ahmed K, Challacombe B, Khan MS, Popert R, Dasgupta P. Systematic review of prostate cancer risk and association with consumption of fish and fish-oils: analysis of 495,321 participants. Int J Clin Practoce Blackwell Publishing Ltd  2015; 69(1): 87-105.
[http://dx.doi.org/10.1111/ijcp.12514] 
[269] 
Aucoin M, et al. Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic ReviewIntegrative Cancer Therapies. SAGE
 Publications Inc  2017; 16(1): 32-62.
[http://dx.doi.org/10.1177/1534735416656052] 
[270] 
Bardo MT, Neisewander JL, Kelly TH. Individual differences and social influences on the neurobehavioral pharmacology of abused drugs. Pharmacol Rev  2013; 65(1): 255-90.
[http://dx.doi.org/10.1124/pr.111.005124] [PMID: 23343975] 
[271] 
Gage H, et al. Views of parents in four European countries about the effect of food on the mental performance of primary school children. Eur J Clin Nutr  2014; 68: 32-7.
[http://dx.doi.org/10.1038/ejcn.2013.214] 
[272] 
Kris-Etherton PM, Grieger JA, Etherton TD. Dietary reference intakes for DHA and EPA. Prostaglandins Leukot Essent Fatty Acids  2009; 81(2-3): 99-104.
[http://dx.doi.org/10.1016/j.plefa.2009.05.011] [PMID: 19525100] 
Rights & Permissions Print Cite
Article Metrics
7
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/1381612826666200429094158	Print ISSN 1381-6128
Publisher Name Bentham Science Publisher	Online ISSN 1873-4286
Current Pharmaceutical Design

Omega-3 Fatty Acids and Vulnerability to Addiction: Reviewing Preclinical and Clinical Evidence

Abstract Play Pause

Related Journals

Related Books

Related Articles

Abstract
